1.28M
international patient visits
Reported for key foreign-facing hospitals. Scope may include foreign nationals, Hong Kong/Macau/Taiwan patients, residents in China, and medical travelers.
China medical travel insights
More international patients are comparing China for medical care.
Public reports point to rising foreign-facing hospital activity, dedicated medical travel, and demand across complex care, TCM, dental care, checkups, and selected innovative therapies. The signal is meaningful, but the data must be read by scope.
Data interpretation
01Treat large numbers as public trend signals, not guarantees.
02Do not add hospital visits, medical travel, and city counts together.
03Read each chart with its scope note before comparing figures.
Last reviewed: May 10, 2026. This page summarizes public reports and known limitations.
Key data points
Four useful numbers, each with a different scope.
These numbers help frame the market, but they are not a single dataset. Each card states the reporting scope to reduce overclaiming.
413K
dedicated medical-travel visits
Industry-report figure focused on people traveling to mainland China mainly for medical care. It uses a narrower scope than hospital visit counts.
73.6%
three-year growth signal
Reported growth versus 2022 for the broader foreign-facing hospital visit scope. It should not be applied to every city or treatment area.
RMB 3.58B
estimated market size
Industry estimate for China's international medical sector, including several patient categories and reporting scopes.
Growth signals
The trend is up, but the lines should stay separate.
Hospital visit activity, dedicated medical travel, and city-level examples describe different parts of the market. A clean chart should compare direction, not merge the counts.
2023 recovery signals
Local rebounds in Shanghai and Shenzhen
2024 broader recovery
Industry estimates above 500K medical-travel visits
2025 acceleration
1.28M foreign-facing hospital visits; 413K dedicated medical-travel visits
Visual scale is directional. It summarizes publicly reported growth signals and is not a precise national time-series dataset.
Source regions
Use a regional signal matrix, not a false-precision pie chart.
Largest base
Asia
Japan, Korea, Mongolia, Southeast Asia, South Asia, and nearby cross-border patient flows form the broadest reported base.
Strong growth
Europe & North America
Public reports point to rising interest from the United States, Canada, Germany, the United Kingdom, France, Italy, Spain, and Australia.
Fast-growing
Russia & Central Asia
Border cities and northern hospitals report repeat visits from Russian, Mongolian, and Central Asian patients.
Emerging demand
Middle East
Some hospitals are adapting service details such as prayer space, halal food, and international coordination for Gulf-region patients.
Smaller but present
Africa
Demand is visible among students, business communities, residents in China, and selected medical-travel cases.
Treatment areas
Reported demand spans complex care and practical elective needs.
This list reflects recurring public-report themes. It is not a ranking and does not imply every hospital offers international-ready care in each area.
01Oncology and access to selected innovative therapies
02Cardiovascular care and interventional procedures
03Neurology, rehabilitation, and complex pediatric cases
04Traditional Chinese medicine and integrative recovery
05Dental care, ophthalmology, and elective procedures
06Health checkups and preventive medicine
07Boao Lecheng access to selected international medicines and devices
Strengths
Why China enters the comparison set.
01Shorter waiting times in selected public and private hospital pathways
02Lower reported out-of-pocket costs for some diagnostics and procedures
03Large clinical volume in major specialist hospitals
04Distinctive TCM, rehabilitation, and integrative-care options
05Policy advantages in special zones such as Boao Lecheng
Current gaps
What patients should clarify before traveling.
01English and cross-cultural communication varies by hospital and department
02International insurance direct billing is not consistently available
03Medical travel, recovery, translation, and follow-up often need better coordination
04Foreign-patient services remain concentrated in major cities and special zones
05Public data is fragmented and should be interpreted by scope
Data scope and limitations
The cautious reading is the credible reading.
01Figures on this page come from public reporting, local health authority disclosures, hospital releases, media reports, and industry research. They are not a single unified national registry.
02Hospital visit counts, medical-travel counts, foreign passport counts, and Hong Kong/Macau/Taiwan-inclusive counts use different scopes and should not be added together.
03Regional signals are directional summaries from public reports, not precise market-share percentages.
04GoChinaMed is not a hospital or clinic. This page is informational and does not provide diagnosis, treatment recommendations, or a guarantee of availability, price, or outcome.
Use the trend as context, then plan around your own case.
GoChinaMed helps international patients organize their records, questions, city options, timeline, and practical support needs before contacting providers.